Comparison of clinical efficacy between fluticasone propionate/ formoterol (FFC) and fluticasone furoate/ vilanterol (VFC) in patients with asthma
- Conditions
- Bronchial Asthma
- Registration Number
- JPRN-UMIN000031039
- Lead Sponsor
- Ikeda Clinic
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 24
Not provided
1. Patients with evident ACO or COPD comorbidities 2. Patients with antibiotic-resistant infections, deep mycosis, or tuberculosis disease 3. Patients who have been afflicted with a respiratory infection (viral infection) within 8 weeks prior to enrollment 4. Patients with a smoking history of at least 10 pack years 5. Patients who have experienced side effects from the use of ICS, LABA or the combined medications 6. Patients who have used systemic steroids within 4 weeks prior to enrollment 7. Patients with significant heart, liver, kidney disease or other clinically significant comorbidities 8. Patients who are pregnant, breastfeeding, or plan to become pregnant during the study period 9. Other patients who are judged unsuitable for inclusion by the investigators in the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method